Timing of Heparin Discontinuation Before Hip Surgery
Unfractionated heparin (UFH) infusion should be stopped 4-6 hours before hip surgery to completely eliminate its anticoagulant effect. 1, 2
Unfractionated Heparin (UFH) Management
Preoperative Discontinuation
- Stop the UFH infusion 4-6 hours prior to the surgical incision to allow complete elimination of anticoagulant activity 1, 2
- UFH has a half-life of approximately 60-90 minutes, though this can vary between 30-120 minutes depending on the degree of anticoagulation at discontinuation 3, 2
- This 4-6 hour interval ensures the anticoagulant effect is fully eliminated before the procedure begins 1
Special Considerations for Neuraxial Anesthesia
- Neuraxial procedures (spinal or epidural anesthesia) are absolutely contraindicated under active anticoagulation 3, 1
- If spinal or epidural anesthesia is planned for hip surgery, ensure the UFH has been stopped for the full 4-6 hours and coagulation parameters have normalized 3
- The risk of spinal cord hematoma is a critical concern when combining anticoagulation with neuraxial techniques 3
Postoperative Resumption of Heparin
Timing of Restart
- UFH can be restarted without a bolus dose more than 4 hours after removal of the epidural catheter or surgical drain 1, 2
- For standard hip surgery with controlled hemostasis, restart UFH at ≥24 hours postoperatively using a lower-intensity infusion without bolus dosing 1
- Avoid bolus doses when restarting to minimize bleeding risk 1
Risk-Stratified Approach
- For low-bleeding risk situations: Full therapeutic-dose heparin can be restarted within 24 hours once hemostasis is confirmed 1
- For high-bleeding risk procedures (including major hip surgery): Delay full therapeutic anticoagulation for 48-72 hours postoperatively 1
- Consider intermediate-dose or prophylactic-dose heparin during the initial 48-72 hour period to balance thrombotic and bleeding risks 1
Important Clinical Pitfalls
Avoid These Common Errors
- Do not restart heparin too early postoperatively, as this significantly increases major bleeding risk—rates can reach up to 20% when bridging therapy is given too close to surgery 1
- Do not use bolus dosing when restarting UFH after major orthopedic surgery 1
- Do not perform neuraxial procedures while the patient has any residual anticoagulant effect from heparin 3, 1
Monitoring Considerations
- Point-of-care hemoglobin analyzers should be used routinely at the end of hip surgery to assess anemia and guide transfusion decisions 3
- Core temperature monitoring should be routine, as older patients undergoing hip surgery are particularly susceptible to hypothermia 3
Alternative Anticoagulants in Special Situations
If the patient has heparin-induced thrombocytopenia (HIT), different timing applies: